ERK1-independent α-secretase cut of β-amyloid precursor protein via M1 muscarinic receptors and PKCα/ε

Molecular and Cellular Neuroscience

Volumn 47, Issue 3, 2011, Pages 223-232

  Cisse, Moustapha ^a   Braun, Ursula ^b   Leitges, Michael ^b   Fisher, Abraham ^c   Pages, Gilles ^a   Checler, Frédéric ^a   Vincent, Bruno ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b UNIVERSITY OF OSLO   (Norway)

^c ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

secretase; ADAM17; Disintegrins; ERK; Muscarinic receptors; Phosphorylation; Protein kinase C

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ADAM PROTEIN; ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; CARBACHOL; MITOGEN ACTIVATED PROTEIN KINASE 3; MUSCARINIC M1 RECEPTOR; PHORBOL DIBUTYRATE; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; THREONINE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CANCER CELL; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; FIBROBLAST CULTURE; GENE INACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SECRETION; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION;

ADAM PROTEINS; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CELL LINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICE; NEURONS; PHOSPHORYLATION; PROTEIN KINASE C-ALPHA; PROTEIN KINASE C-EPSILON; RECEPTOR, MUSCARINIC M1;

EID: 79957646992     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2011.04.008     Document Type: Article

References (51)

1. Alfa Cissé, M., Duplan, E., Guillot-Sestier, M.V., Rumigny, J., Druon, C., Pages, G., Orzechowski, H.D., Slack, B.E., Checler F., Vincent, B. The extracellular regulated kinase-1 (ERK1) controls regulated a-secretase-mediated processing, promoter transactivation and mRNA levels of the cellular prion protein. (submitted).
2. Alfa Cissé M., Sunyach C., Lefranc-Jullien S., Postina R., Vincent B., Checler F. The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity. J. Biol. Chem. 2005, 281:40624-40631.
3. Alfa Cissé M., Sunyach C., Slack B.E., Fisher A., Vincent B., Checler F. M1 and M3 muscarinic receptors control physiological processing of cellular prion by modulating ADAM17 phosphorylation and activity. J. Neurosci. 2007, 27:4083-4092.
4. Alfa Cissé M., Louis K., Braun U., Mari B., Leitges M., Slack B.E., Fisher A., Auberger P., Checler F., Vincent B. Isoform-specific contribution of protein kinase C to prion processing. Mol. Cell. Neurosci. 2008, 39:400-410.
5. Alkon D.L., Sun M.K., Nelson T.J. PKC signalling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease. Trends Neurosci. 2007, 28:51-60.
6. Black R.A., Durie C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., Cerretti D.P. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997, 385:729-733.
7. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-259.
8. Brunet A., Pagès G., Pouysségur J. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene 1994, 9:3379-3387.
9. Buxbaum J.D., Gandy S.E., Cicchetti P., Ehrlich M.E., Czernik A.J., Fracasso R.P., Ramabhadran T.V., Unterbeck A.J., Greengard P. Processing of Alzheimer β/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:6003-6006.
10. Buxbaum J.D., Liu K.N., Luo Y., Slack J.L., Stocking K.L., Peschon J.J., Johnson R.S., Castner B.J., Cerretti D.P., Black R.A. Evidence that tumor necrosis factor α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 1998, 273:27765-27767.
11. Caccamo A., Oddo S., Billings L.M., Green K.N., Martinez-Coria H., Fisher A., LaFerla F.M. M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 2006, 49:671-682.
12. Checler F. Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 1995, 65:1431-1444.
13. Checler F., Vincent B. Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators. Trends Neurosci. 2002, 25:616-620.
14. Davies P., Maloney A.J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976, 2:1403.
15. Diaz-Rodriguez E., Montero J.C., Esparis-Ogando A., Yuste L., Pandiella A. Extracellular signal-regulated kinase phosphorylates tumor necrosis factor α-converting enzyme at threonine 735: a potential role in regulated shedding. Mol. Biol. Cell 2002, 13:2031-2044.
16. Dudley D.T., Pang L., Decker S.J., Bridges A.J., Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:7686-7689.
17. Fan H., Turck C.W., Derynck R. Characterization of growth factor-induced serine phosphorylation of tumor-necrosis factor-α converting enzyme and on alternative translated polypeptide. J. Biol. Chem. 2003, 278:18617-18627.
18. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 1998, 273:18623-18632.
19. He G., Luo W., Li P., Remmers C., Netzer W.J., Hendrick J., Bettayeb K., Flajolet M., Gorelick F., Wennogle L.P., Greengard P. Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease. Nature 2010, 467:95-98.
20. Jorissen E., Prox J., Bernreuther C., Weber S., Schwanbeck R., Serneels L., Snellinx A., Craessaerts K., Thathiah A., Tesseur A., Bartsch U., Weskamp G., Blobel C.P., Glatzel M., De Strooper B., Saftig P. The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J. Neurosci. 2010, 30:4833-4844.
21. Kim M.L., Zhang B., Mills I.P., Milla M.E., Brunden K.R., Lee V.M.Y. Effects of TNFα-converting enzyme inhibition on amyloid β production and APP processing in vitro and in vivo. J. Neurosci. 2008, 28:12052-12061.
22. Kinouchi T., Sorimachi H., Maruyama K., Mizuno K., Ohno S., Ishiura S., Suzuki K. Conventional protein kinase C (PKC)-α and novel PKCε, but not -δ, increase the secretion of an N-terminal fragments of Alzheimer's disease amyloid precursor protein from PKC cDNA transfected 3Y1 fibroblasts. FEBS Lett. 1995, 364:203-206.
23. Koike H., Tomioka S., Sorimachi H., Saido T.C., Maruyama K., Okuyama A., Fujisawa-Sehara A., Ohno S., Suzuki K., Ishiura S. Membrane-anchored metalloprotease MDC9 has an α-secretase activity responsible for processing the amyloid precursor protein. Biochem. J. 1999, 343:371-375.
24. Kojro E., Gimpl S., Lammich S., Marz W., Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM10. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:5815-5820.
25. Kuhn P.H., Wang H., Dislich B., Colombo A., Zeitschel U., Ellwart J.W., Kremmer E., Roβner S., Lichtenthaler S.F. ADAM10 is the physiologically relevant, constitutive α-secretase of the amyloid precursor protein in primary neurons. EMBO J. 2010, 29:3020-3032.
26. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C., Fahrenholz F. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:3922-3927.
27. Lannfelt L., Basun H., Wahlund L.O., Rowe B.A., Wagner S.L. Decreased alpha-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease. Nat. Med. 1995, 1:829-832.
28. Lopez-Perez E., Zhang Y., Frank S.J., Creemers J., Seidah N., Checler F. Constitutive α-secretase cleavage of the β-amyloid precursor protein in the furin-deficient LoVo cell line: involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM10. J. Neurochem. 2001, 76:1532-1539.
29. Louis K., Guérineau N., Fromigue O., Defamie V., Collazos A., Anglard P., Shipp M.A., Auberger P., Joubert D., Mari B. Tumor cell-mediated induction of the stromal factor stromelysin-3 requires heterotypic cell contact-dependent activation of specific protein kinase C isoforms. J. Biol. Chem. 2005, 280:1272-1283.
30. Luo W.J., Wang H., Li H., Kim B.S., Shah S., Lee H.J., Thinakaran G., Kim T.W., Yu G., Xu H. PEN-2 and APH-1 coordinately regulate proteolytic processing of presenilin 1. J. Biol. Chem. 2003, 278:7850-7854.
31. Matsushima H., Shimohama S., Chachin M., Taniguchi T., Kimura J. Ca2+-dependent and Ca2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease. J. Neurochem. 1996, 67:317-323.
32. Naslavsky N., Stein R., Yanai A., Friedlander G., Taraboulos A. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J. Biol. Chem. 1997, 272:6324-6331.
33. Nitsch R.M., Slack B.E., Wurtman R.J., Growdon J.H. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 1992, 258:304-307.
34. Pagès G., Lenormand P., L'Allemain G., Chambard J.C., Meloche S., Pouysségur J. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:8319-8323.
35. Pagès G., Brunet A., L'Allemain G., Pouysségur J. Constitutive mutant and putative regulatory serine phosphorylation site of mammalian MAP kinase linase (MEK1). EMBO J. 1994, 13:3003-3010.
36. Pagès G., Guérin S., Grall D., Bonino F., Smith A., Anjuere F., Auberger P., Pouysségur J. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 1999, 286:1374-1377.
37. Ponte P., Gonzalez, Dewhitt P., Schilling J., Miller J., Hsu D., Greenberg B., Davis K., Wallace W., Lieberburg I., Fuller F., Cordell B. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 1988, 331:525-527.
38. Postina R., Schroeder A., Dewachter I., Bohl J., Schmitt U., Kojro E., Prinzen C., Endres K., Hiemke C., Blessing M., Flamez P., Dequenne A., Godaux E., van Leuven F., Fahrenholz F. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J. Clin. Invest. 2004, 113:1456-1464.
39. Pruessmeyer J., Ludwig A. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer. Semin. Cell Dev. Biol. 2009, 20:164-174.
40. Saito N., Itouji A., Totani Y., Osawa I., Koide H., Fujisawa N., Ogita K., Tanaka C. Cellular and intracellular localization of epsilon-subspecies of protein kinase C in the rat brain: presynaptic localization of the epsilon-subspecies. Brain Res. 1993, 607:241-248.
41. Saitoh T., Sundsmo M., Roch J.M., Kimura N., Cole G., Schubert D., Oltersdorf T., Schenk D.B. Secreted form of amyloid β protein precursor is involved in the growth regulation of fibroblasts. Cell 1989, 58:615-622.
42. Slack B.E., Nitsch R.M., Livneh E., Kunz G.M., Breu J., Eldar H., Wurtman R.J. Regulation by phorbol esters of amyloid precursor protein release from Swiss 3T3 fibroblasts overexpressing protein kinase Cα. J. Biol. Chem. 1993, 268:21097-21101.
43. Soond S., Everson B., Riches D.W.H., Murphy G. ERK-mediated phosphorylation of Thr735 in TNFα-converting enzyme and its potential role in TACE protein trafficking. J. Cell Sci. 2005, 118:2371-2380.
44. Suh Y.H., Checler F. Amyloid precursor protein, presenilins, and α-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacol. Rev. 2002, 54:469-525.
45. Vincent B., Beaudet A., Dauch P., Vincent J.P., Checler F. Distinct properties of neuronal and astrocytic endopeptidase 3.4.24.16: a study on differentiation, subcellular distribution and secretion processes. J. Neurosci. 1996, 16:5049-5059.
46. Vincent B., Paitel E., Frobert Y., Lehmann S., Grassi J., Checler F. Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons. J. Biol. Chem. 2000, 275:35612-35616.
47. Vincent B., Paitel E., Saftig P., Frobert Y., Hartmann D., De Strooper B., Grassi J., Lopez-Perez E., Checler F. The disintegrin ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J. Biol. Chem. 2001, 276:37743-37746.
48. Xu D., Sharma C., Hemler M.E. Tetraspanin 12 regulates ADAM10-dependent cleavage of amyloid precursor protein. FASEB J. 2009, 23:3674-3681.
49. Zimmermann M., Borroni B., Cattabeni F., Padovani A., Di Luca M. Cholinesterase inhibitors influence APP metabolism in Alzheimer diseases patients. Neurobiol. Dis. 2005, 19:237-242.
50. Zhang Q., Thomas S.M., Wai Yan Lui V., Xi S., Siegfried J.M., Fan H., Smithgall T.E., Mills G.B., Grandis J.R. Phosphorylation of TNF-α converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation. Proc. Natl. Acad. Sci. USA 2006, 103:6901-6906.
51. Zhu G., Wang D., Lin Y.H., McMahon T., Koo E.H., Messing R.O. Protein kinase Cα suppresses Aβ production and promotes activation of α-secretase. Biochem. Biophys. Res. Commun. 2001, 285:997-1006.